Laboratorios Farmaceuticos Rovi SA (XMAD:ROVI)
€ 88.2 0.4 (0.46%) Market Cap: 4.51 Bil Enterprise Value: 4.55 Bil PE Ratio: 33.53 PB Ratio: 8.48 GF Score: 88/100

Full Year 2020 Laboratorios Farmaceuticos ROVI SA Earnings Call Transcript

Feb 24, 2021 / 02:00PM GMT
Release Date Price: €45.5 (-0.44%)
Operator

Ladies and gentlemen, welcome to ROVI Full Year 2020 financial results. The management of ROVI will run you through the presentation, which will be followed by a Q&A session. Mr. Juan López-Belmonte, Chief Executive Officer; and Mr. Javier López-Belmonte, Chief Financial Officer of ROVI, will be presenting this conference. I will now pass the word to Mr. Javier López-Belmonte. Please, sir, go ahead.

Javier López;Belmonte Encina
Laboratorios Farmaceuticos Rovi, S.A. - Second Deputy Chairman & CFO

Thank you very much, and good afternoon to everyone. This is Javier López-Belmonte, CFO of ROVI. At this time, I would like to welcome everybody to this full year 2020 results conference call, which will start in a moment. Let me please first introduce Rovi's attendees today, Mr. Juan López-Belmonte, CEO; Marta Campos, Head of Investor Relations; Antonio Marquina, Investor Relations; and myself. All lines are now mute to prevent any background noise. The conference will also be webcasted on ROVI website. After the presentation, as the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot